Add to my selection

CARVYKTI (ciltacabtagene autoleucel)

Medicine - Posted on Sep 25 2023

Active substance (DCI)

ciltacabtagene autoleucel

history (2)

6/23/22

CARVYKTI (ciltacabtagene autoleucel) - Myélome multiple

Autorisation d’accès précoce octroyée à la spécialité CARVYKTI (ciltacabtagene autoleucel) dans l'indication « le traitement...

icône flèche
11/23/22

CARVYKTI (ciltacabtagene autoleucel) - Myélome multiple

Key points Approval of reimbursement for the treatment of adult patients with relapsed and refractory multiple myeloma, who ...

CAV :
54321

icône flèche

Technical information

ATC code

Manufacturer

JANSSEN-CILAG

Presentation

CARVYKTI (ciltacabtagene autoleucel) 3,2 x 106 – 1,0 × 108 cellules dispersion pour perfusion
Poche de perfusion de 30 mL ou 70 mL - (Code CIP : 34009 550 891 1 7)

All our publications

Anemia and hemoglobinopathies

Congenital, genetic and rare diseases

Drug therapy

Paediatrics

My account

You do not have a saved search

No element in selection

CARVYKTI (ciltacabtagene autoleucel)

CARVYKTI (ciltacabtagene autoleucel) - Myélome multiple

CARVYKTI (ciltacabtagene autoleucel) - Myélome multiple

Follow us :